Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Pliant Therapeutics
PLRX
$114M
| $27.5K | ﹤0.01% |
2,028
-171
| -8% | -$2.32K |
|
1377
Under Armour
UAA
$2.2B
| $27.5K | ﹤0.01% |
+3,277
| New | +$27.5K |
|
1378
Paylocity
PCTY
$9.62B
| $27.4K | ﹤0.01% |
137
-81
| -37% | -$16.2K |
|
1379
Prothena Corp
PRTA
$460M
| $27.1K | ﹤0.01% |
1,793
-152
| -8% | -$2.3K |
|
1380
Companhia Siderúrgica Nacional
SID
$1.99B
| $27.1K | ﹤0.01% |
18,696
-664
| -3% | -$963 |
|
|
MOMO
1381
Hello Group
MOMO
$1.37B
| $27.1K | ﹤0.01% |
3,714
-379
| -9% | -$2.76K |
|
|
NXRT
1382
NexPoint Residential Trust
NXRT
$879M
| $26.6K | ﹤0.01% |
638
-262
| -29% | -$10.9K |
|
|
BDN
1383
Brandywine Realty Trust
BDN
$759M
| $26.6K | ﹤0.01% |
4,819
-1,868
| -28% | -$10.3K |
|
1384
Lincoln Electric
LECO
$13.5B
| $26.2K | ﹤0.01% |
138
-84
| -38% | -$15.9K |
|
1385
Tetra Tech
TTEK
$9.48B
| $26.2K | ﹤0.01% |
657
-393
| -37% | -$15.7K |
|
1386
Maravai LifeSciences
MRVI
$363M
| $26K | ﹤0.01% |
4,727
-393
| -8% | -$2.16K |
|
1387
Castle Biosciences
CSTL
$683M
| $25K | ﹤0.01% |
933
-70
| -7% | -$1.88K |
|
1388
Woodward
WWD
$14.6B
| $24.6K | ﹤0.01% |
145
-89
| -38% | -$15.1K |
|
1389
Weibo
WB
$2.87B
| $24.6K | ﹤0.01% |
2,574
-91
| -3% | -$868 |
|
1390
Relay Therapeutics
RLAY
$710M
| $24.3K | ﹤0.01% |
5,578
+735
| +15% | +$3.21K |
|
1391
Aaon
AAON
$6.64B
| $24.2K | ﹤0.01% |
+199
| New | +$24.2K |
|
|
SAFE
1392
Safehold
SAFE
$1.17B
| $24.1K | ﹤0.01% |
1,296
-506
| -28% | -$9.43K |
|
1393
Erasca
ERAS
$457M
| $23.9K | ﹤0.01% |
9,421
-797
| -8% | -$2.02K |
|
1394
Ironwood Pharmaceuticals
IRWD
$188M
| $23.7K | ﹤0.01% |
5,333
-444
| -8% | -$1.98K |
|
1395
Tyra Biosciences
TYRA
$674M
| $23.7K | ﹤0.01% |
+1,686
| New | +$23.7K |
|
1396
CureVac
CVAC
$1.21B
| $23.7K | ﹤0.01% |
7,476
-637
| -8% | -$2.02K |
|
1397
Humacyte
HUMA
$226M
| $23.6K | ﹤0.01% |
4,288
-29
| -0.7% | -$160 |
|
|
PGRE
1398
Paramount Group
PGRE
$1.66B
| $23.5K | ﹤0.01% |
4,855
-1,893
| -28% | -$9.18K |
|
1399
Evolus
EOLS
$495M
| $23.4K | ﹤0.01% |
2,110
-172
| -8% | -$1.91K |
|
1400
Cullinan Oncology
CGEM
$413M
| $23.3K | ﹤0.01% |
1,940
-157
| -7% | -$1.89K |
|